JP2023033281A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023033281A5 JP2023033281A5 JP2022198753A JP2022198753A JP2023033281A5 JP 2023033281 A5 JP2023033281 A5 JP 2023033281A5 JP 2022198753 A JP2022198753 A JP 2022198753A JP 2022198753 A JP2022198753 A JP 2022198753A JP 2023033281 A5 JP2023033281 A5 JP 2023033281A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- composition
- antibody
- light chain
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims description 14
- 108060003951 Immunoglobulin Proteins 0.000 claims description 3
- 102000018358 immunoglobulin Human genes 0.000 claims description 3
- 229940072221 immunoglobulins Drugs 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 claims description 2
- 229920003192 poly(bis maleimide) Polymers 0.000 claims description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- 238000004132 cross linking Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000003568 thioethers Chemical class 0.000 claims 2
- SOYPUUFPUFRXRI-UHFFFAOYSA-N 1,5-dibromo-2,4-dimethylbenzene Chemical group CC1=CC(C)=C(Br)C=C1Br SOYPUUFPUFRXRI-UHFFFAOYSA-N 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 125000005179 haloacetyl group Chemical group 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 239000012491 analyte Substances 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- IPJGAEWUPXWFPL-UHFFFAOYSA-N 1-[3-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC(N2C(C=CC2=O)=O)=C1 IPJGAEWUPXWFPL-UHFFFAOYSA-N 0.000 description 1
- RQKQQZAZSOOCFT-UHFFFAOYSA-N 1-[5-(2,5-dioxopyrrol-1-yl)naphthalen-1-yl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC2=C(N3C(C=CC3=O)=O)C=CC=C12 RQKQQZAZSOOCFT-UHFFFAOYSA-N 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1603291.4A GB201603291D0 (en) | 2016-02-25 | 2016-02-25 | Antibodies |
| GB1603291.4 | 2016-02-25 | ||
| US201662368606P | 2016-07-29 | 2016-07-29 | |
| US62/368,606 | 2016-07-29 | ||
| PCT/GB2017/050489 WO2017144900A1 (en) | 2016-02-25 | 2017-02-24 | Mass spectrometry kit |
| JP2018544901A JP7246927B2 (ja) | 2016-02-25 | 2017-02-24 | 質量分析キット |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544901A Division JP7246927B2 (ja) | 2016-02-25 | 2017-02-24 | 質量分析キット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023033281A JP2023033281A (ja) | 2023-03-10 |
| JP2023033281A5 true JP2023033281A5 (https=) | 2024-05-09 |
| JP7541070B2 JP7541070B2 (ja) | 2024-08-27 |
Family
ID=55806928
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544901A Active JP7246927B2 (ja) | 2016-02-25 | 2017-02-24 | 質量分析キット |
| JP2022017497A Active JP7541045B2 (ja) | 2016-02-25 | 2022-02-07 | 質量分析キット |
| JP2022198753A Active JP7541070B2 (ja) | 2016-02-25 | 2022-12-13 | 質量分析キット |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544901A Active JP7246927B2 (ja) | 2016-02-25 | 2017-02-24 | 質量分析キット |
| JP2022017497A Active JP7541045B2 (ja) | 2016-02-25 | 2022-02-07 | 質量分析キット |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12461108B2 (https=) |
| EP (2) | EP4123308A1 (https=) |
| JP (3) | JP7246927B2 (https=) |
| KR (1) | KR102851057B1 (https=) |
| CN (2) | CN116148479A (https=) |
| AU (1) | AU2017222399B2 (https=) |
| DK (1) | DK3420361T3 (https=) |
| ES (1) | ES2936783T3 (https=) |
| GB (1) | GB201603291D0 (https=) |
| WO (1) | WO2017144900A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201708262D0 (en) | 2017-05-23 | 2017-07-05 | Binding Site Group Ltd | Assay for plasma cell associated disease |
| CA3126712A1 (en) * | 2019-01-31 | 2020-08-06 | Regeneron Pharmaceuticals, Inc. | Native microfluidic ce-ms analysis of antibody charge heterogeneity |
| CN110009008B (zh) * | 2019-03-18 | 2020-11-06 | 四川大学 | 基于提取的免疫固定电泳图特征对其进行自动分类的方法 |
| GB201906599D0 (en) | 2019-05-10 | 2019-06-26 | Binding Site Group Ltd | Mass spectrometry calibrator |
| WO2020229794A1 (en) | 2019-05-10 | 2020-11-19 | The Binding Site Group Limited | Mass spectrometry calibrator |
| GB201915946D0 (en) | 2019-11-01 | 2019-12-18 | Binding Site Group Ltd | Quantitation of immunoglobulins i n mass spectrometry |
| GB202007047D0 (en) * | 2020-05-13 | 2020-06-24 | Binding Site Group Ltd | Mass spectrometry controls |
| GB202008887D0 (en) * | 2020-06-11 | 2020-07-29 | Binding Site Group Ltd | A method of identifying or characterising an immune response in a subject |
| GB202016822D0 (en) | 2020-10-23 | 2020-12-09 | Binding Site Group Ltd | Quantitation of immunoglobulins in mass spectrometry |
| CN113720900A (zh) * | 2021-09-14 | 2021-11-30 | 首都医科大学附属北京朝阳医院 | 一种基于madli-tof ms技术检测血清中m蛋白的方法 |
| CN114324557B (zh) * | 2021-12-03 | 2024-05-10 | 融智生物科技（青岛）有限公司 | 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6290090A (en) | 1989-08-29 | 1991-04-08 | University Of Southampton | Bi-or trispecific (fab)3 or (fab)4 conjugates |
| WO1991006570A1 (en) * | 1989-10-25 | 1991-05-16 | The University Of Melbourne | HYBRID Fc RECEPTOR MOLECULES |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| ES2242189T3 (es) * | 1994-05-13 | 2005-11-01 | Miltenyi Biotec Gmbh | Columna esteril y apirogena copulada a una proteina con miras a la fijacion y extraccion de sustancias dadas de la sangre. |
| JP2826965B2 (ja) * | 1995-01-12 | 1998-11-18 | オリエンタル酵母工業株式会社 | 免疫吸着体とその製造法 |
| EP0862584B1 (en) | 1995-11-03 | 2004-12-22 | The Binding Site Limited | Production of antibodies |
| US6207370B1 (en) * | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
| US6897044B1 (en) | 1999-01-28 | 2005-05-24 | Biogen Idec, Inc. | Production of tetravalent antibodies |
| WO2005035721A2 (en) * | 2003-10-08 | 2005-04-21 | Ebioscience | Native immunoglobulin binding reagents and methods for making and using same |
| GB0501741D0 (en) * | 2005-01-27 | 2005-03-02 | Binding Site The Ltd | Antibody |
| CA2600844A1 (en) * | 2005-03-14 | 2006-09-21 | Medimmune, Inc. | Macromolecules comprising a thioether cross-link |
| US7781178B2 (en) | 2005-04-12 | 2010-08-24 | Akira Matsumori | Biomarker for diagnosing heart disease and the use thereof |
| US7893616B2 (en) * | 2006-02-27 | 2011-02-22 | Ohio State University | Process to determine enzyme activity |
| US20100015652A1 (en) | 2006-12-21 | 2010-01-21 | Brian Walter Granda | Antibody quantitation |
| RU2012118620A (ru) | 2009-10-09 | 2013-11-20 | Симфоген А/С | Множественное количественное определение в смеси индивидуальных рекомбинантных белков посредством сигнатурных пептидов и масс-спектрометрии |
| GB201001946D0 (en) | 2010-02-05 | 2010-03-24 | Binding Site Group The Ltd | Cancer prognostic assay |
| GB2478520A (en) | 2010-03-02 | 2011-09-14 | Binding Site Group Ltd | Kidney prognostic assay |
| GB201117172D0 (en) | 2011-10-05 | 2011-11-16 | Binding Site Group The Ltd | Diabetes |
| GB201121265D0 (en) | 2011-12-12 | 2012-01-18 | Binding Site Group The Ltd | Assay |
| JP2015510877A (ja) * | 2012-03-09 | 2015-04-13 | ユーシーエル ビジネス パブリック リミテッド カンパニー | 抗体の化学修飾 |
| WO2014121031A1 (en) | 2013-01-31 | 2014-08-07 | Excelimmune, Inc. | Characterization of antibody mixtures by mass spectrometry |
| WO2015131169A2 (en) * | 2014-02-28 | 2015-09-03 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Personalized myeloma detection |
| WO2015154052A1 (en) | 2014-04-04 | 2015-10-08 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| EP3175242A4 (en) * | 2014-07-29 | 2017-12-27 | Mayo Foundation for Medical Education and Research | Quantifying monoclonal antibody therapeutics by lc-ms/ms |
| PT3209767T (pt) * | 2014-10-21 | 2020-11-09 | Gennova Biopharmaceuticals Ltd | Um novo processo de purificação para isolamento e produção comercial de tnk-tpa recombinante (tenecteplase) |
| CN108026164A (zh) | 2015-09-24 | 2018-05-11 | 梅约医学教育与研究基金会 | 通过质谱鉴定免疫球蛋白游离轻链 |
| GB201708262D0 (en) * | 2017-05-23 | 2017-07-05 | Binding Site Group Ltd | Assay for plasma cell associated disease |
-
2016
- 2016-02-25 GB GBGB1603291.4A patent/GB201603291D0/en not_active Ceased
-
2017
- 2017-02-24 CN CN202211574983.0A patent/CN116148479A/zh active Pending
- 2017-02-24 WO PCT/GB2017/050489 patent/WO2017144900A1/en not_active Ceased
- 2017-02-24 AU AU2017222399A patent/AU2017222399B2/en active Active
- 2017-02-24 US US16/078,986 patent/US12461108B2/en active Active
- 2017-02-24 JP JP2018544901A patent/JP7246927B2/ja active Active
- 2017-02-24 ES ES17708320T patent/ES2936783T3/es active Active
- 2017-02-24 EP EP22190012.9A patent/EP4123308A1/en active Pending
- 2017-02-24 KR KR1020187027703A patent/KR102851057B1/ko active Active
- 2017-02-24 CN CN201780013491.5A patent/CN108885218A/zh active Pending
- 2017-02-24 EP EP17708320.1A patent/EP3420361B1/en active Active
- 2017-02-24 DK DK17708320.1T patent/DK3420361T3/da active
-
2022
- 2022-02-07 JP JP2022017497A patent/JP7541045B2/ja active Active
- 2022-12-13 JP JP2022198753A patent/JP7541070B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023033281A5 (https=) | ||
| JP2022069446A5 (https=) | ||
| JP7541070B2 (ja) | 質量分析キット | |
| KR102910595B1 (ko) | 형질세포 연관 질환용 검정 | |
| CN106443016B (zh) | 用于检测多特异性结合物的结合搭档的方法 | |
| US20230391851A1 (en) | Antibodies | |
| JP2016540212A (ja) | 多価多重特異性分子の生物学的活性を決定するためのｓｐｒベースの架橋アッセイ | |
| US20080176254A1 (en) | Affinity separation compositions and methods | |
| Matos et al. | A purification platform for antibodies and derived fragments using a de novo designed affinity adsorbent | |
| JPWO2017144900A5 (https=) | ||
| JP2017532570A (ja) | エフェクター機能抑制型ヒトまたはヒト化薬物抗体に対する抗薬物抗体の決定方法 | |
| JP6420281B2 (ja) | タンパク質解析用固相担体及びその製造方法 | |
| JP7241888B2 (ja) | ｐＨ勾配ＳＰＲに基づく結合アッセイ | |
| CN115698724A (zh) | 质谱对照 | |
| HK40087264A (en) | Mass spectrometry kit | |
| Star et al. | Intact Mass Spectrometry Analysis of Immuno-Isolated Human Therapeutic Antibodies from Serum | |
| WO2023103005A1 (zh) | 一种利用亲和层析介质富集抗体的方法及其应用 | |
| WO2012175201A1 (en) | Methods for the characterization of antibodies |